In particular, instability of the linker and heterogeneity of the product (i.e., broad distribution of DARs) often negatively impacts ADC efficacy and therapeutic window, which often leads to difficulty or limitation in the optimization for clinical application and eventual failure in clinical trials
Toxic epidermal necrolysis: part II
Also note that monthly costs may increase as your dose escalates, since higher doses require more medication per injection
If you're interested in exploring whether twice-weekly dosing or other modifications could improve your results, discuss this with your healthcare provider before making changes
Although it is not an FDA-approved formulation, hydroxocobalamin is recommended worldwide by the World Health Organization (WHO) as a drug of choice for the treatment of vitamin B12 deficiency
Once again, Big Pharma is weaponizing the US judicial system to limit consumer choice